Global Hyperpigmentation Disorder Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Hyperpigmentation Disorder Treatment Market is presumed to reach the market size of nearly USD 11.73 MN by 2030 from USD 5.8 MN in 2022 with a CAGR of 9.21% under the study period 2023 - 2030.

Hyperpigmentation disorder treatments are procedures to treat hyperpigmentation which is a skin-related concern. Pigmentation refers to patches on the darkened skin compared to the surrounding skin, typically resulting in a patchy or uneven look. Hyperpigmentation occurs when melanocytes, a skin-darkening pigment, generate melanin in the deep skin layers. An overproduction of melanin can cause dark patches of skin. A reduction in melanin synthesis results in skin hypopigmentation. Cosmeceuticals, laser therapy, and chemical peels can all be used to treat hyperpigmentation issues.

Market Dynamics:

Increasing investments in research and development for cutting-edge technology may encourage market expansion for hyperpigmentation disorder treatments. The diminishing of social stigma associated with pigmentation may also aid market growth. The increased prevalence of hyperpigmentation-related disorders and increased awareness of skin rejuvenation and treatment alternatives are projected to boost the hyperpigmentation disorder treatment market. Companies involved in treating hyperpigmentation disorders are benefiting financially from cosmeceutical technological improvements and the resulting rise in cosmeceutical usage in skincare hence, expanding the hyperpigmentation disorder treatment market. Key players are boosting their investments in nanotechnology to develop innovative and new solutions that will help to broaden the hyperpigmentation disorder treatment market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hyperpigmentation disorder treatment. The growth and trends of hyperpigmentation disorder treatment industry provide a holistic approach to this study.

Market Segmentation:

This section of the hyperpigmentation disorder treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment Type

Cosmeceuticals
Laser Therapy
Chemical Peels
Microdermabrasion
Phototherapy
Others

By Disease Indication

Melasma
Post-Inflammatory Hyperpigmentation
Solar Lentigines
Others

By End-User

Hospitals
Esthetic Clinics & Dermatology Centers
Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Hyperpigmentation Disorder Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hyperpigmentation disorder treatment market include Aerolase Corporation, Candela Corporation, Cynosure, Galderma S.A., iSCLINICAL, ISDIN, L'Oreal (SkinCeuticals, Skinbetterscience & La Roche-Posay), LumenisBe Ltd., Mesoestetics, Obagi Cosmeceuticals LLC, PCA Skin, Scientis, Sente, SkinMedica (AbbVie), SoltaMedical, ZO Skin Health Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11219996

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . HYPERPIGMENTATION DISORDER TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment Type
- 3.7.2 Market Attractiveness Analysis By Disease Indication
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HYPERPIGMENTATION DISORDER TREATMENT MARKET ANALYSIS BY TREATMENT TYPE

6.1 Overview by Treatment Type
6.2 Historical and Forecast Data
6.3 Analysis by Treatment Type
6.4 Cosmeceuticals Historic and Forecast Sales by Regions
6.5 Laser Therapy Historic and Forecast Sales by Regions
6.6 Chemical Peels Historic and Forecast Sales by Regions
6.7 Microdermabrasion Historic and Forecast Sales by Regions
6.8 Phototherapy Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL HYPERPIGMENTATION DISORDER TREATMENT MARKET ANALYSIS BY DISEASE INDICATION

7.1 Overview by Disease Indication
7.2 Historical and Forecast Data
7.3 Analysis by Disease Indication
7.4 Melasma Historic and Forecast Sales by Regions
7.5 Post-inflammatory Hyperpigmentation Historic and Forecast Sales by Regions
7.6 Solar Lentigines Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL HYPERPIGMENTATION DISORDER TREATMENT MARKET SALES ANALYSIS BY END-USER

8.1 Overview by End-user
8.2 Historical and Forecast Data
8.3 Analysis by End-user
8.4 Hospitals Historic and Forecast Sales by Regions
8.5 Esthetic Clinics & Dermatology Centers Historic and Forecast Sales by Regions
8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL HYPERPIGMENTATION DISORDER TREATMENT MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE HYPERPIGMENTATION DISORDER TREATMENT COMPANIES

10.1. Hyperpigmentation Disorder Treatment Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF HYPERPIGMENTATION DISORDER TREATMENT INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Aerolase Corporation
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Candela Corporation
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Cynosure
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Galderma S.A.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. iSCLINICAL
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. ISDIN
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. L'Oreal (SkinCeuticals Skinbetterscience & La Roche-Posay)
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. LumenisBe Ltd.
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Mesoestetics
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Obagi Cosmeceuticals LLC
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. PCA Skin
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments
11.14. Scientis
- 11.14.1. Company Overview
- 11.14.2. Company Revenue
- 11.14.3. Products
- 11.14.4. Recent Developments
11.15. Sente
- 11.15.1. Company Overview
- 11.15.2. Company Revenue
- 11.15.3. Products
- 11.15.4. Recent Developments
11.16. SkinMedica (AbbVie)
- 11.16.1. Company Overview
- 11.16.2. Company Revenue
- 11.16.3. Products
- 11.16.4. Recent Developments
11.17. SoltaMedical
- 11.17.1. Company Overview
- 11.17.2. Company Revenue
- 11.17.3. Products
- 11.17.4. Recent Developments
11.18. ZO Skin Health Inc.
- 11.18.1. Company Overview
- 11.18.2. Company Revenue
- 11.18.3. Products
- 11.18.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies